Enter your search terms:
Top

Uncategorized

Aquestive Therapeutics Launches SYMPAZAN™ (clobazam) Oral Film with Widespread U.S. Availability

November, 29 2018 at 12:16 PM EST Establishes extensive Authorized Distributor Network to ensure easy access through retail pharmacies nationwide and mail order WARREN, N.J., Nov. 29, 2018 /PRNewswire/ -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a specialty pharmaceutical company focused on identifying, developing and commercializing differentiated products...

Aquestive Therapeutics Announces Closing of Exercise of Underwriters’ Over-Allotment Option in Initial Public Offering

WARREN, N.J., Aug. 15, 2018 /PRNewswire/ -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a specialty pharmaceutical company focused on identifying, developing and commercializing differentiated products to address unmet medical needs, today announced the underwriters of its previously announced initial public offering of common stock have partially exercised their over-allotment option to...

Court Ruling in Favor of Aquestive Therapeutics Enjoining Dr. Reddy’s Laboratories from Launching its Generic Suboxone Product

WARREN, N.J., July 16, 2018 /PRNewswire/ -- Aquestive Therapeutics ("Aquestive") announces today that the U.S. District Court for the District of New Jersey has granted Aquestive together with Indivior PLC (LON: INDV) and its U.S. subsidiary, Indivior Inc., a preliminary injunction against Dr. Reddy's Laboratories ("DRL"), mandating the restrictions...